šš®šŗš¶š¹š¹š² š”. šš¼ššš¼š» (š§š§š¦ šš±šš°š®šš¶š¼š» ššµš®š¶šæ) š®š»š± š°š¼-šµš¼šš š¦šš²š³š®š» š. š§šš¹š¹š¶šš (šš±š¶šš¼šæ-š¶š»-ššµš¶š²š³, šš³š¢šÆš“š±šš¢šÆšµš¢šµšŖš°šÆ šš¼ššæš»š®š¹š) š“š±š¦š¢š¬ šøšŖšµš© ššæš®š±š¹š²š š. šš®šæš±š¶š»š²šæ š®šÆš¼ššµ šµš¶š šµš¦š¢š®āš“ šæš²š°š²š»šš¹šŗ š½ššÆš¹š¶ššµš²š± šŗš®š»šš“š°šæš¶š½š š¶š» šš³š¢šÆš“š±šš¢šÆšµš¢šµšŖš°šÆ: āšš¹š¼šÆš®š¹ ššŗšŗšš»š² šš¶š¼šŗš®šæšøš²šæš š®š»š± šš¼š»š¼šæ š¦š²šæš¼ššš®ššš šš®š» š£šæš²š±š¶š°š šššš¼šŗš²š“š®š¹š¼šš¶šæšš šš»š³š²š°šš¶š¼š» šŖš¶ššµš¶š» š¦š²šæš¼š½š¼šš¶šš¶šš² ššš»š“ š§šæš®š»šš½š¹š®š»š š„š²š°š¶š½š¶š²š»šš.ā
š„š²š®š± ššµš² š®šæšš¶š°š¹š²:
https://journals.lww.com/transplantjo...
šš²š®šæš»š¶š»š“ š¢šÆš·š²š°šš¶šš²š
1. Discuss the role of immune biomarkers in predicting CMV and other infections in lung transplant recipients.
2. Explore advantages and limitations of absolute lymphocyte count (ALC) as a predictor.
3. Review data from Gardiner et al. evaluating ALC and mitogen values as predictors of CMV in R+ lung transplant recipients.
4. Highlight recent TTS CMV guidelines relevant to this topic.
ā
šš¼š¹š¹š¼š & šš²š®šæš» š š¼šæš²
ā¢ š§š§š¦: https://tts.org
ā¢ š§šæš®š»šš½š¹š®š»šš®šš¶š¼š» šš¼ššæš»š®š¹š: https://transplantjournal.com
This podcast is for educational purposes and is not a substitute for professional medical advice.